Health care stocks were declining pre-bell Thursday, with The Health Care Select Sector SPDR Fund (XLV) down 0.9% and the iShares Biotechnology ETF (IBB) 0.7% lower.
Takeda Pharmaceutical (TAK) shares were down more than 0.5% after the company reported lower fiscal Q4 core earnings.
Argenx (ARGX) stock was more than 8% lower after the company posted operating income that trailed analysts' expectations.
Stevanato Group (STVN) shares were up over 1% after the company reported higher Q1 adjusted earnings and revenue.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。